Hydromorphone Hydrochloride Tablet
Product Images NDC 43602-003

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 43602-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascent Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2-500 (2 50)

This is a description of the NDC 43602-002-05 Hydrocodone Hydrochloride Tablets USP 2mg. It provides information about the dosage, storage instructions, manufacturing details, and precautions for dispensing. The tablets are to be dispensed in a tight, light-resistant container with a child-resistant closure and a Medication Guide should be provided to each patient separately.*

FDA Label Image

2 (2)

Description: This text contains information about NDC 43602-002-30 Hydrochloride Tablets, USP, used for Hydrocodone administration. The storage conditions are specified as between 30°C to 25°C. It instructs to dispense in a light-resistant container and provides guidance on combining it with other substances. The pharmacist is advised to dispense the Medication Guide provided and to reject if the seal over the bottle is broken. The text mentions something related to "Spmebecape Crening" and is signed off by ASCENT Central Islip, NY 11722.*

FDA Label Image

4-500 (4 50)

Each tablet contains 4 mg of Hydromorphone Hydrochloride, USP. The usual dosage can be found in the package insert. Store at room temperature and dispense in a tight, light-resistant container. This medication is manufactured by Ascent Pharmaceuticals, Inc., located in Central Islip, NY.*

FDA Label Image

4 (4)

The text contains information about NDC 43602-003-30 Hydrochloride Tablets, USP (Hydromorphone) with dosage instructions and storage recommendations. It advises dispensing in a tight light-resistant container with a child-resistant closure and includes a note for pharmacists to provide a Medication Guide. The tablets are supposed to be stored at 20°C to 25°C. The text also includes the manufacturer's address: ASCENT, Central Islip, NY 11722.*

FDA Label Image

8-500 (8 50)

This is a label for Hydrocodone Hydrochloride Tablets, USP containing 8 mg of Hydromorphone. The medication guide needs to be provided to each patient. The tablets come in a bottle of 500 tablets and should be stored at 20°C to 25°C. The prescription must be dispensed in a tight, light-resistant container with a child-resistant closure. The manufacturer is Ascent Pharmaceuticals, Inc. from Central Islip, NY. Refer to package insert for complete prescribing information.*

FDA Label Image

8 (8)

This is a description for a medication labeled as NDC 43602-004-30, with the generic name Hydrocodone Hydrochloride Tablets, USP. Each tablet contains 5 mg of the active ingredient. The prescription medication is intended for oral use, with 30 tablets per bottle. It is essential to consult the Medication Guide for proper usage. The manufacturer is Ascent Pharmaceuticals, Inc. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and kept in a tight, light-resistant container with a child-resistant closure. Be cautious and do not use if the seal over the bottle opening is broken or missing.*

FDA Label Image

Structure (Hydromo Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.